| - GRCh37:
- Chr2:227963433
- GRCh38:
- Chr2:227098717
| COL4A4 | G394V | Alport syndrome | Likely pathogenic (Apr 5, 2023) | no assertion criteria provided |
| - GRCh37:
- ChrX:107911717
- GRCh38:
- ChrX:108668487
| COL4A5 | G1258V | Alport syndrome | Likely pathogenic (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228122356
- GRCh38:
- Chr2:227257640
| COL4A3, MFF-DT | G342D | Alport syndrome | Uncertain significance (Sep 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107938139
- GRCh38:
- ChrX:108694909
| COL4A5 | Y1597*, Y1603* | X-linked Alport syndrome | Pathogenic (Nov 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227906976
- GRCh38:
- Chr2:227042260
| COL4A4 | | not provided | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227958970
- GRCh38:
- Chr2:227094254
| COL4A4 | G414C | Alport syndrome | Likely pathogenic (Nov 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107911647
- GRCh38:
- ChrX:108668417
| COL4A5 | G1235C | Alport syndrome | Likely pathogenic (Apr 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107824259
- GRCh38:
- ChrX:108581029
| COL4A5 | | Alport syndrome | Pathogenic (Feb 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107909824
- GRCh38:
- ChrX:108666594
| COL4A5 | G1185R | Alport syndrome | Likely pathogenic (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228137829
- GRCh38:
- Chr2:227273113
| COL4A3, MFF-DT | E641D | not provided | Conflicting interpretations of pathogenicity (Aug 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:227922015
- GRCh38:
- Chr2:227057299
| COL4A4 | | not provided | Benign (Jul 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227921977
- GRCh38:
- Chr2:227057261
| COL4A4 | | not provided | Benign (Jul 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228154759
- GRCh38:
- Chr2:227290043
| COL4A3, MFF-DT | G1009fs | not provided, Alport syndrome | Pathogenic/Likely pathogenic (Apr 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227896926
- GRCh38:
- Chr2:227032210
| COL4A4 | P1215L | not provided, Benign familial hematuria, Autosomal recessive Alport syndrome
| Uncertain significance (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227915731
- GRCh38:
- Chr2:227051015
| COL4A4 | R1038G | not provided | Uncertain significance (Apr 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228155592
- GRCh38:
- Chr2:227290876
| COL4A3, MFF-DT | P1067L | Autosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome, not provided | Uncertain significance (Sep 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227968699
- GRCh38:
- Chr2:227103983
| COL4A4 | K269E | not provided | Uncertain significance (Sep 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227924210
- GRCh38:
- Chr2:227059494
| COL4A4 | G765V | not provided | Uncertain significance (Oct 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227915806
- GRCh38:
- Chr2:227051090
| COL4A4 | H1013Y | not provided, Inborn genetic diseases, Benign familial hematuria, Autosomal recessive Alport syndrome | Uncertain significance (Feb 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227907835
- GRCh38:
- Chr2:227043119
| COL4A4 | R1119G | not provided | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:227887194
- GRCh38:
- Chr2:227022478
| COL4A4 | | not provided | Likely benign (Jan 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227915829
- GRCh38:
- Chr2:227051113
| COL4A4 | G1005E | not provided, Benign familial hematuria, Autosomal recessive Alport syndrome
| Conflicting interpretations of pathogenicity (Sep 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:227892728-227892729
- GRCh38:
- Chr2:227028012-227028013
| COL4A4 | | not provided | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228144567
- GRCh38:
- Chr2:227279851
| COL4A3, MFF-DT | | not provided | Likely benign (Apr 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227872724-227872725
- GRCh38:
- Chr2:227008008-227008009
| COL4A4 | | not provided | Likely benign (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228137793
- GRCh38:
- Chr2:227273077
| COL4A3, MFF-DT | | not provided | Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228172502
- GRCh38:
- Chr2:227307786
| COL4A3, MFF-DT | | not provided | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228115876
- GRCh38:
- Chr2:227251160
| COL4A3, MFF-DT | | not provided | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228102686-228102687
- GRCh38:
- Chr2:227237970-227237971
| COL4A3, MFF-DT | K34fs | Autosomal dominant Alport syndrome, Benign familial hematuria, Autosomal recessive Alport syndrome, not provided | Pathogenic (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228113209-228113210
- GRCh38:
- Chr2:227248493-227248494
| COL4A3, MFF-DT | L175fs | not provided | Pathogenic (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228124595
- GRCh38:
- Chr2:227259879
| COL4A3, MFF-DT | | not provided | Likely pathogenic (Apr 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107920819
- GRCh38:
- ChrX:108677589
| COL4A5 | G1294S, G1300S | not provided, Alport syndrome | Likely pathogenic (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227976431
- GRCh38:
- Chr2:227111715
| COL4A4 | | Benign familial hematuria, Autosomal recessive Alport syndrome, not provided
| Likely pathogenic (Jul 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:18055457
- GRCh38:
- Chr17:18152143
| MYO15A | P2642L | not provided, Alport syndrome | Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr21:37833945
- GRCh38:
- Chr21:36461647
| CLDN14, CLDN14-AS1 | G17S | Alport syndrome | Uncertain significance (Apr 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228109668
- GRCh38:
- Chr2:227244952
| COL4A3, MFF-DT | G94A | not provided | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227974009
- GRCh38:
- Chr2:227109293
| COL4A4 | | Benign familial hematuria, Autosomal recessive Alport syndrome, not provided
| Uncertain significance (Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227872849
- GRCh38:
- Chr2:227008133
| COL4A4 | R1565H | not provided | Uncertain significance (Nov 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228109073
- GRCh38:
- Chr2:227244357
| COL4A3, MFF-DT | G91D | not provided | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228173942
- GRCh38:
- Chr2:227309226
| COL4A3, MFF-DT | A1555T | not provided | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228175517
- GRCh38:
- Chr2:227310801
| COL4A3, MFF-DT | T1594S | not provided | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228173943
- GRCh38:
- Chr2:227309227
| MFF-DT, COL4A3 | A1555V | not provided | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:227886889
- GRCh38:
- Chr2:227022173
| COL4A4 | G1364V | not provided | Uncertain significance (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228172428
- GRCh38:
- Chr2:227307712
| COL4A3, MFF-DT | P1419T | not provided | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227906935
- GRCh38:
- Chr2:227042219
| COL4A4 | G1145E | not provided | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227967860
- GRCh38:
- Chr2:227103144
| COL4A4 | | not provided | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227924118
- GRCh38:
- Chr2:227059402
| COL4A4 | | not provided | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227924893
- GRCh38:
- Chr2:227060177
| COL4A4 | R708I | not provided | Conflicting interpretations of pathogenicity (Oct 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:228118051
- GRCh38:
- Chr2:227253335
| COL4A3, MFF-DT | R229W | not provided | Uncertain significance (Jan 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228155508
- GRCh38:
- Chr2:227290792
| MFF-DT, COL4A3 | G1039E | not provided | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227953528
- GRCh38:
- Chr2:227088812
| COL4A4 | N488K | Autosomal recessive Alport syndrome, Benign familial hematuria, not provided
| Uncertain significance (Dec 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228173922
- GRCh38:
- Chr2:227309206
| COL4A3, MFF-DT | C1548Y | not provided | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227953521
- GRCh38:
- Chr2:227088805
| COL4A4 | L491F | Autosomal recessive Alport syndrome, Benign familial hematuria, not provided
| Conflicting interpretations of pathogenicity (Oct 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:228113217
- GRCh38:
- Chr2:227248501
| COL4A3, MFF-DT | P176R | not specified, not provided | Uncertain significance (Feb 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:227924959
- GRCh38:
- Chr2:227060243
| COL4A4 | G686D | not provided | Uncertain significance (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228029505
- GRCh38:
- Chr2:227164789
| COL4A3 | | not provided | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227967570
- GRCh38:
- Chr2:227102854
| COL4A4 | | not provided | Likely benign (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227920766
- GRCh38:
- Chr2:227056050
| COL4A4 | L871F | not provided | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227973298
- GRCh38:
- Chr2:227108582
| COL4A4 | P245L | Autosomal recessive Alport syndrome, Benign familial hematuria, not provided
| Uncertain significance (Mar 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228004877
- GRCh38:
- Chr2:227140161
| COL4A4 | | not provided | Pathogenic (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:227896707
- GRCh38:
- Chr2:227031991
| COL4A4 | | not provided | Conflicting interpretations of pathogenicity (Aug 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:228175501
- GRCh38:
- Chr2:227310785
| COL4A3, MFF-DT | A1589T | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:228172623
- GRCh38:
- Chr2:227307907
| COL4A3, MFF-DT | G1484R | Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria, Inborn genetic diseases | Uncertain significance (Dec 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228163503
- GRCh38:
- Chr2:227298787
| COL4A3, MFF-DT | G1286V | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:228163410
- GRCh38:
- Chr2:227298694
| COL4A3, MFF-DT | P1255H | Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria, not provided | Conflicting interpretations of pathogenicity (Sep 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:228162559
- GRCh38:
- Chr2:227297843
| COL4A3, MFF-DT | | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:228157950
- GRCh38:
- Chr2:227293234
| COL4A3, MFF-DT | M1085R | Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria, not provided | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228135637
- GRCh38:
- Chr2:227270921
| COL4A3, MFF-DT | V576A | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:228128512
- GRCh38:
- Chr2:227263796
| COL4A3, MFF-DT | | not provided | Likely benign (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228121089
- GRCh38:
- Chr2:227256373
| COL4A3, MFF-DT | | Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria, not provided | Likely benign (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:228118034
- GRCh38:
- Chr2:227253318
| MFF-DT, COL4A3 | I223T | Alport syndrome | Uncertain significance (Nov 5, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227985825
- GRCh38:
- Chr2:227121109
| COL4A4 | P78S | Autosomal recessive Alport syndrome, Benign familial hematuria, not provided
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:227968738
- GRCh38:
- Chr2:227104022
| COL4A4 | P256S | Alport syndrome | Uncertain significance (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227967884
- GRCh38:
- Chr2:227103168
| COL4A4 | | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227967883
- GRCh38:
- Chr2:227103167
| COL4A4 | L283M | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227953407
- GRCh38:
- Chr2:227088691
| COL4A4 | P529S | Alport syndrome | Uncertain significance (Aug 15, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227896874
- GRCh38:
- Chr2:227032158
| COL4A4 | | Alport syndrome | Uncertain significance (Sep 4, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227886885
- GRCh38:
- Chr2:227022169
| COL4A4 | | Alport syndrome | Uncertain significance (Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:227872285
- GRCh38:
- Chr2:227007569
| COL4A4 | Q1610R | Alport syndrome | Uncertain significance (Aug 14, 2020) | no assertion criteria provided |
| - GRCh37:
- ChrX:107814695-107814696
- GRCh38:
- ChrX:108571465-108571466
| COL4A5 | | Alport syndrome | Likely pathogenic (Dec 11, 2016) | no assertion criteria provided |
| - GRCh37:
- ChrX:107910365
- GRCh38:
- ChrX:108667135
| COL4A5 | Q1186* | Alport syndrome | Pathogenic (Oct 25, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107938099
- GRCh38:
- ChrX:108694869
| COL4A5 | P1584H, P1590H | Alport syndrome | Pathogenic (Oct 24, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107850056
- GRCh38:
- ChrX:108606826
| COL4A5 | R777C | not provided | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:228172635
- GRCh38:
- Chr2:227307919
| MFF-DT, COL4A3 | G1488R | Alport syndrome | Uncertain significance (Oct 24, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107930767-107930768
- GRCh38:
- ChrX:108687537-108687538
| COL4A5 | G1454fs, G1460fs | Alport syndrome | Pathogenic (Oct 24, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107840780-107840799
- GRCh38:
- ChrX:108597550-108597569
| COL4A5 | | Alport syndrome | Pathogenic (Oct 24, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107814692
- GRCh38:
- ChrX:108571462
| COL4A5 | P145L | Alport syndrome | Uncertain significance (Jan 9, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107908736
- GRCh38:
- ChrX:108665506
| COL4A5 | | Alport syndrome | Pathogenic (Jun 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:227886782
- GRCh38:
- Chr2:227022066
| COL4A4 | R1400G | not provided | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107865033
- GRCh38:
- ChrX:108621803
| COL4A5 | G893A | Alport syndrome | Pathogenic (Oct 24, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107920804
- GRCh38:
- ChrX:108677574
| COL4A5 | Q1289*, Q1295* | Alport syndrome | Pathogenic (Dec 6, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrX:107845202
- GRCh38:
- ChrX:108601972
| COL4A5 | G710E | Alport syndrome | Likely pathogenic (Oct 24, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrX:107840241
- GRCh38:
- ChrX:108597011
| COL4A5 | P511fs | Alport syndrome | Likely pathogenic (Aug 16, 2019) | no assertion criteria provided |
| - GRCh37:
- ChrX:107845113
- GRCh38:
- ChrX:108601883
| COL4A5 | | Alport syndrome | Likely pathogenic (Jan 28, 2020) | no assertion criteria provided |
| - GRCh37:
- ChrX:107829842
- GRCh38:
- ChrX:108586612
| COL4A5 | | not provided | Uncertain significance (Dec 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- ChrX:107939606
- GRCh38:
- ChrX:108696376
| COL4A5 | | Alport syndrome | Uncertain significance (Apr 3, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr2:227919418
- GRCh38:
- Chr2:227054702
| COL4A4 | G918R | Autosomal recessive Alport syndrome, not provided | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrX:107840236
- GRCh38:
- ChrX:108597006
| COL4A5 | G509R | not provided, X-linked Alport syndrome | Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrX:107929335-107929341
- GRCh38:
- ChrX:108686105-108686111
| COL4A5 | D1425fs, D1431fs | Alport syndrome | Likely pathogenic (May 31, 2018) | no assertion criteria provided |
| - GRCh37:
- ChrX:107807157-107807158
- GRCh38:
- ChrX:108563927-108563928
| COL4A5 | | Alport syndrome | Likely pathogenic (Aug 27, 2018) | no assertion criteria provided |